PSA Speedrun
Practice · Prescription Review
PSA-0033
00:00
FREE SAMPLE
Sample 4 of 10 · no signup needed
ID · PSA-0033Prescription ReviewDuplicate anticoagulation therapyMODERATE
Case presentation
A 76-year-old woman is admitted with a left hemiparesis. CT head excludes haemorrhage. She is found to be in AF (newly diagnosed). The on-call medical team has prescribed: 1) Apixaban 5 mg BD (started today for AF stroke prevention); 2) Enoxaparin 40 mg SC OD (continued from admission for VTE prophylaxis). Renal function is normal. She has no bleeding history. CHA2DS2-VASc 6.
DH. Apixaban 5 mg BD (started); Enoxaparin 40 mg SC OD (continued); Atorvastatin 80 mg ON; Ramipril 5 mg OD
Allergies. NKDA
Observations / investigations
Hb 124, eGFR 78; CT head: no haemorrhage; AF rate-controlled
Task
Tick the prescription(s) representing inappropriate duplicate anticoagulation.
AQuestion A
This patient is receiving therapeutic anticoagulation for AF stroke prevention. Select the ONE prescription that represents inappropriate duplicate (prophylactic) anticoagulation and should be stopped (mark it in column A).
BQuestion B
Given this is an ACUTE ischaemic stroke (CT today, started this admission), select the ONE prescription that should be withheld/deferred because starting it now risks haemorrhagic transformation and its timing should follow the 1-3-6-12 rule (mark it in column B).
MedicineDoseRouteFrequencyAB
Ramipril5 mgoral (PO)once daily
Atorvastatin80 mgoral (PO)once daily at night (ON)
Aspirin75 mgoral (PO)once daily
Enoxaparin40 mgsubcutaneous (SC)once daily
Apixaban5 mgoral (PO)twice daily (BD)
Answer A and B by ticking rows in each column, then submit.
PRESCRIPTION REVIEW
Get the full bank — £19.99/yr